» Articles » PMID: 27331590

Safety, Feasibility, and Acceptability of the PrePex Device for Adult Male Circumcision in Malawi

Abstract

Introduction: Nonsurgical adult male circumcision devices present an alternative to surgery where health resources are limited. This study aimed to assess the safety, feasibility, and acceptability of the PrePex device for adult male circumcision in Malawi.

Methods: A prospective single-arm cohort study was conducted at 3 sites (1 urban static, 1 rural static, 1 rural tent) in Malawi. Adverse event (AE) outcomes were stratified to include/exclude pain, and confidence intervals (CIs) were corrected for clinic-level clustering.

Results: Among 935 men screened, 131 (14.0%) were not eligible, 13 (1.4%) withdrew before placement, and 791 (84.6%) received the device. Moderate and severe AEs totaled 7.1% including pain [95% CI: 3.4-14.7] and 4.0% excluding pain (95% CI: 2.6 to 6.4). Severe AEs included pain (n = 3), insufficient skin removal (n = 4), and early removal (n = 4). Among early removals, 1 had immediate surgical circumcision, 1 had surgery after 48 hours of observation, 1 declined surgery, and 1 did not return to our site although presented at a nearby clinic. More than half of men (51.9%) reported odor; however, few (2.2%) stated they would not recommend the device to others because of odor. Median levels of reported pain (scale, 1-10) were 2 (interquartile range, 2-4) during application and removal, and 0 (interquartile range, 0-2) at all other time points.

Conclusions: Severe AEs were rare and similar to other programs. Immediate provision of surgical services after displacement or early removal proved a challenge. Cases of insufficient skin removal were linked to poor technique, suggesting provider training requires reinforcement and supervision.

Citing Articles

Adverse event profile and associated factors following surgical voluntary medical male circumcision in two regions of Namibia, 2015-2018.

OBryan G, Feldacker C, Ensminger A, Nghatanga M, Brandt L, Shepard M PLoS One. 2021; 16(10):e0258611.

PMID: 34669709 PMC: 8528325. DOI: 10.1371/journal.pone.0258611.


Description of adverse events among adult men following voluntary medical male circumcision: Findings from a circumcision programme in two provinces of South Africa.

Muchiri E, Charalambous S, Ginindza S, Maraisane M, Maringa T, Vranken P PLoS One. 2021; 16(8):e0253960.

PMID: 34403409 PMC: 8370616. DOI: 10.1371/journal.pone.0253960.


Is the PrePex device an alternative for surgical male circumcision in adolescents ages 13-17 years? Findings from routine service delivery during active surveillance in Zimbabwe.

Mavhu W, Hatzold K, Madidi N, Maponga B, Dhlamini R, Munjoma M PLoS One. 2019; 14(3):e0213399.

PMID: 30856228 PMC: 6411138. DOI: 10.1371/journal.pone.0213399.


Adverse event profile of a mature voluntary medical male circumcision programme performing PrePex and surgical procedures in Zimbabwe.

Bochner A, Feldacker C, Makunike B, Holec M, Murenje V, Stepaniak A J Int AIDS Soc. 2017; 19(1):21394.

PMID: 28362066 PMC: 5467584. DOI: 10.7448/IAS.20.1.21394.


VMMC Devices-Introducing a New Innovation to a Public Health Intervention.

Ridzon R, Reed J, Sgaier S, Hankins C J Acquir Immune Defic Syndr. 2016; 72 Suppl 1:S1-4.

PMID: 27331583 PMC: 4936419. DOI: 10.1097/QAI.0000000000000967.

References
1.
Mutabazi V, Kaplan S, Rwamasirabo E, Bitega J, Ngeruka M, Savio D . One-arm, open-label, prospective, cohort field study to assess the safety and efficacy of the PrePex device for scale-up of nonsurgical circumcision when performed by nurses in resource-limited settings for HIV prevention. J Acquir Immune Defic Syndr. 2013; 63(3):315-22. DOI: 10.1097/QAI.0b013e31828e6412. View

2.
Mutabazi V, Bitega J, Ngeruka L, Hategekimana T, Kaplan S, Karema C . Non-surgical adult male circumcision using the PrePex device: task-shifting from physicians to nurses. Afr J Reprod Health. 2014; 18(1):61-70. View

3.
Bitega J, Ngeruka M, Hategekimana T, Asiimwe A, Binagwaho A . Safety and efficacy of the PrePex device for rapid scale-up of male circumcision for HIV prevention in resource-limited settings. J Acquir Immune Defic Syndr. 2011; 58(5):e127-34. DOI: 10.1097/QAI.0b013e3182354e65. View

4.
Bailey R, Moses S, Parker C, Agot K, Maclean I, Krieger J . Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007; 369(9562):643-56. DOI: 10.1016/S0140-6736(07)60312-2. View

5.
Kigozi G, Musoke R, Watya S, Kighoma N, Nkale J, Nakafeero M . The safety and acceptance of the PrePex device for non-surgical adult male circumcision in Rakai, Uganda. A non-randomized observational study. PLoS One. 2014; 9(8):e100008. PMC: 4140666. DOI: 10.1371/journal.pone.0100008. View